The effect on clinical outcome of glutamine supplementation of parenteral nutrition in the surgical newborn infant

ISRCTN ISRCTN83168963
DOI https://doi.org/10.1186/ISRCTN83168963
Secondary identifying numbers SP3763
Submission date
30/04/2003
Registration date
30/04/2003
Last edited
09/10/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Agostino Pierro
Scientific

Paediatric Surgery Unit
Institute of Child Health
30 Guilford Street
London
WC1N 1EH
United Kingdom

Phone +44 (0)20 7272 2814
Email SIGN.Trial@ich.ucl.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymSIGN (Surgical Infants Glutamine Nutrition)
Study objectivesWe will test the hypothesis that glutamine supplementation in the parenteral nutrition (PN) of surgical infants determines more rapid recovery of intestinal function and reduction in infection rate.
Ethics approval(s)Ethics approval received from local medical ethics committee (ref: 2/4/002).
Health condition(s) or problem(s) studiedSurgical newborn infants on parenteral nutrition
InterventionThe treatment group will receive glutamine-supplemented parenteral nutrition.
The control group will receive isonitrogenous parenteral nutrition.

All patients will have data collected once a week on clinical state, feeding, liver and renal function tests, ammonia, septic episodes and parenteral nutrition lines
Intervention typeSupplement
Primary outcome measure1. Infection: episodes of sepsis and septicaemia, timing of sepsis and septicaemia
2. Intestinal function: time to full enteral feeding and time on (days)
Secondary outcome measures1. Growth
2. Nutrient intake
3. Biochemical measures of hepatic function
Overall study start date01/04/2002
Completion date30/09/2004

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants250
Key inclusion criteria1. Surgical infants below the age of 3 months, either sex
2. Require parenteral nutrition
3. Have received less than 5 days of parenteral nutrition already
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/04/2002
Date of final enrolment30/09/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Paediatric Surgery Unit
London
WC1N 1EH
United Kingdom

Sponsor information

Action Medical Research (UK)
Charity

Vincent House
Horsham West Sussex
RH12 2DP
United Kingdom

Website http://www.action.org.uk/
ROR logo "ROR" https://ror.org/01wcqa315

Funders

Funder type

Charity

Action Medical Research (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
actionmedres, action medical research for children, AMR
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2012 Yes No